Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data-Reference-Cited by-同舟云学术

Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data

Published:2024-04-19 Issue:1 Volume:27 Page:531-542
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Niegisch Günter¹²^ORCID,Grimm Marc-Oliver³^ORCID,Hardtstock Fraence⁴^ORCID,Krieger Julia⁴^ORCID,Starry Alexandra⁴^ORCID,Osowski Ulrike⁵,Deiters Barthold⁶^ORCID,Maywald Ulf⁷,Wilke Thomas⁸^ORCID,Kearney Mairead⁹

Affiliation:

1. Department of Urology, University Hospital and Medical Faculty of the Heinrich-Heine-University, Düsseldorf, Germany

2. Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Germany

3. Department of Urology, University Hospital Jena, Jena, Germany

4. Cytel, Berlin, Germany

5. Merck Healthcare Germany GmbH, Weiterstadt, Germany, an affiliate of Merck KGaA

6. GWQ ServicePlus AG, Düsseldorf, Germany

7. Drug Department, AOK PLUS, Dresden, Germany

8. IPAM e.V., Wismar, Germany

9. Merck Healthcare KGaA, Darmstadt, Germany

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2331893

Reference42 articles.

1. Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future

2. World Health Organization. Bladder fact sheet [cited 2022 Nov 08]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-bladder-fact-sheet.pdf

3. Witjes JA Bruins HM Carrión A et al. EAU guidelines on muscle-invasive and metastatic bladder cancer; 2022 [cited 2022 Nov 07]. Available from: https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer

4. Epidemiology and Risk Factors of Urothelial Bladder Cancer

5. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base